Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
Boston Scientific reports it will likely fail to meet its sales and profit forecasts for the year 2026 following a cyberattack that caused operational disruptions. The company stated its current status and provided an update regarding its recovery efforts and financial outlook. Market reaction was swift, with company stock falling after the announcement. Industry analysts are evaluating the full extent of the financial damage to the bottom line and how long the medical device maker will take to fully restore normal business operations across its network.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Boston Scientific announced it is unlikely to meet its sales and profit forecast for 2026 following a cyberattack.
- ✓ The cyberattack disrupted operations at Boston Scientific.
- ✓ Boston Scientific's stock fell following the announcement regarding its earnings guidance.
What changed
Boston Scientific officially announced it is unlikely to achieve its 2026 sales and profit forecasts due to a recent cyberattack.
Live updates
-
Boston Scientific Misses 2026 Forecasts Following Cyberattack
Boston Scientific reports it will likely fail to meet its sales and profit forecasts for the year 2026 following a cyberattack that caused operational disruptions. The company stated its current status and provided an update regarding its recovery efforts and financial outlook. Market reaction was swift, with company stock falling after the announcement. Industry analysts are evaluating the full extent of the financial damage to the bottom line and how long the medical device maker will take to fully restore normal business operations across its network.
Why it matters
Cybersecurity incidents targeting major healthcare and medical device companies pose severe operational and financial risks, directly affecting supply chains and revenue projections. Boston Scientific holds a major position in medical technology, making disruptions to its sales and profit guidance a significant event for broader market observers. The latest disclosure highlights the vulnerability of critical medical infrastructure to digital intrusions.
What is confirmed
- Boston Scientific announced it is unlikely to meet its sales and profit forecast for 2026 following a cyberattack.
- The cyberattack disrupted operations at Boston Scientific.
- Boston Scientific's stock fell following the announcement regarding its earnings guidance.
Still unconfirmed
- The company is on the road to recovery following the cyberattack.
What to watch next
- Further financial updates from Boston Scientific detailing the exact monetary losses from the cyberattack.
- Additional disclosures concerning the timeline for complete operational recovery.
confidence 100%Sources used for this update (8)
- wsj.com — Boston Scientific Won’t Meet Guidance Due to Cyberattack
- Reuters — Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
- finance.yahoo.com — Boston Scientific on road to recovery following cyberattack
- Bloomberg.com — Boston Scientific Unlikely to Meet Forecasts After Cyber Attack
- Barron's — Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.
- The Register — Boston Scientific left nursing its bottom line after cyberattack
- Yahoo Finance — Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead?
- health.economictimes.indiatimes.com — Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community